Medicinal Cannabis is now officially regulated by more than 50 countries toward the treatment of over 60 unique conditions.

Next-generation cannabis products such as edibles, topicals and extracts, are becoming more mainstream.

Book an appointment to speak with one our Senior Investment Consultants

Book an Appointment

Orange River Capital are offering a direct equity investment into an already operational medicinal cannabis facility in South Africa producing high grade medicinal cannabis.

• Currently Revenue Generating: NET Profit for Year Ending Feb 22 was $1,604,155
• 15% Fixed Annual Dividend Paid Biannually
• 5 Year Term
• Projected 300% Capital Growth
• £10,000 or $25,000 Minimum Investment
Book an Appointment

Sign up to receive our latest news